These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 20172348)

  • 21. Formulation and in vitro and in vivo availability of diclofenac sodium enteric-coated beads.
    Hosny EA; el-Mahrouk GM; Gouda MW
    Drug Dev Ind Pharm; 1998 Jul; 24(7):661-6. PubMed ID: 9876511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
    Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is there variability in drug release and physical characteristics of amiodarone chloride from different commercially available tablets? Possible therapeutic implications.
    Ngo SN; Barnes T
    Int J Pharm Pract; 2010 Aug; 18(4):245-8. PubMed ID: 20636678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of enteric-coated mycophenolate sodium in stable pediatric renal transplant recipients.
    Ettenger R; Bartosh S; Choi L; Zhu W; Niederberger W; Campestrini J; Bastien MC; Schmouder R
    Pediatr Transplant; 2005 Dec; 9(6):780-7. PubMed ID: 16269051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of enteric-coated mycophenolate sodium in stable liver transplant recipients.
    Perry TW; Christians U; Trotter JF; Bendrick-Peart J
    Clin Transplant; 2007; 21(3):413-6. PubMed ID: 17488394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Elevated pH on the Commercial Enteric-Coated Omeprazole Pellets Resistance: Patent Review and Multisource Generics Comparison.
    Mohylyuk V; Yerkhova A; Katynska M; Sirko V; Patel K
    AAPS PharmSciTech; 2021 Jun; 22(5):188. PubMed ID: 34159427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Solid Lipid Nanoparticles of Mycophenolate Mofetil: An Attempt to Control the Release of an Immunosuppressant.
    Iqbal A; Zaman M; Wahab Amjad M; Adnan S; Abdul Ghafoor Raja M; Haider Rizvi SF; Mustafa MW; Farooq U; Abbas G; Shah S
    Int J Nanomedicine; 2020; 15():5603-5612. PubMed ID: 32848390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Towards a Better Understanding of the Post-Gastric Behavior of Enteric-Coated Formulations.
    Katona MT; Kakuk M; Szabó R; Tonka-Nagy P; Takács-Novák K; Borbás E
    Pharm Res; 2022 Jan; 39(1):201-211. PubMed ID: 35043354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eight enteric-coated 50 mg diclofenac sodium tablet formulations marketed in Saudi Arabia: in vitro quality evaluation.
    Hammami MM; Hussein RF; AlSwayeh R; Alvi SN
    BMC Res Notes; 2020 Sep; 13(1):428. PubMed ID: 32928294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo evaluation of controlled-release and enteric-coated formulations of sodium salicylate.
    Borgström L; Ekman B; Larsson H; Leden I; Lindahl A; Melander A; Wåhlin-Boll E
    Biopharm Drug Dispos; 1984; 5(3):261-72. PubMed ID: 6487753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physical compatibility and chemical stability of mycophenolate mofetil during simulated Y-site administration with commonly coadministered drugs.
    Cochran BG; Sowinski KM; Fausel C; Overholser BR
    Am J Health Syst Pharm; 2007 Jul; 64(13):1410-4. PubMed ID: 17592007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dissolution test for liquid formulations of omeprazole enteric-coated products.
    Jang HJ; Kang BC; Shin WG; Lee S
    Ann Pharmacother; 2003 Jan; 37(1):150-1. PubMed ID: 12503954
    [No Abstract]   [Full Text] [Related]  

  • 36. Enteric-coated mycophenolate sodium: a new option for GHVD prophylaxis?
    Isidori A; Loscocco F; Malerba L; Clissa C; Guiducci B; Visani G
    Eur J Haematol; 2017 Apr; 98(4):320-321. PubMed ID: 26800509
    [No Abstract]   [Full Text] [Related]  

  • 37. Enteric coating of mycophenolate sodium: a rational approach to limit topical gastrointestinal lesions and extend the therapeutic index of mycophenolate.
    Bjarnason I
    Transplant Proc; 2001; 33(7-8):3238-40. PubMed ID: 11750388
    [No Abstract]   [Full Text] [Related]  

  • 38. Myfortic in pediatric transplantation.
    Zimmerhackl LB; Jungraithmayr T; Wiesmayr S; Filler G
    Pediatr Transplant; 2008 Sep; 12(6):614-6. PubMed ID: 18518910
    [No Abstract]   [Full Text] [Related]  

  • 39. Physiologically relevant dissolution conditions towards improved in vitro - in vivo relationship - A case study with enteric coated pantoprazole tablets.
    Amaral Silva D; Gomes Davanço M; Davies NM; Krämer J; de Oliveira Carvalho P; Löbenberg R
    Int J Pharm; 2021 Aug; 605():120857. PubMed ID: 34229072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Degradation products of mycophenolate mofetil in aqueous solution.
    Hooijmaaijer E; Brandl M; Nelson J; Lustig D
    Drug Dev Ind Pharm; 1999 Mar; 25(3):361-5. PubMed ID: 10071831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.